References
- Demerson C. A., Humber L. G., Phillip A. H. Etodolic acid and related compounds. Chemistry and anti-inflammatory actions of some potent di- and trisubstituted 1,3,4,9-tetrahydropyrano [3,4-b] indole-1-acetic acids. J. Med. Chem. 1976; 19: 391–3951. Demerson C. A., Humber L. G., Phillip A. H. Etodolic acid and related compounds. Chemistry and anti-inflammatory actions of some potent di- and trisubstituted 1,3,4,9-tetrahydropyrano [3,4-b] indole-1-acetic acids. J. Med. Chem. 1976; 19: 391–395
- Jacob G. B., Hart K. K., Mullane J. R., Lutins S., Lee T. Y. Placebo-controlled study of etodolac and aspirin in the treatment of rheumatoid arthritis. Curr. Ther. Res. 1983; 33: 703–7132. Jacob G. B., Hart K. K., Mullane J. R., Lutins S., Lee T. Y. Placebo-controlled study of etodolac and aspirin in the treatment of rheumatoid arthritis. Curr. Ther. Res. 1983; 33: 703–713
- Jacob G., Messina M., Caperton E., Gordon R., Harris G., Sack B., Vreede P., Weitzman R. Safety and efficacy of etodolac, once or twice a day, in the treatment of active rheumatoid arthritis. Curr. Ther. Res. 1985; 37: 1124–11293. Jacob G., Messina M., Caperton E., Gordon R., Harris G., Sack B., Vreede P., Weitzman R. Safety and efficacy of etodolac, once or twice a day, in the treatment of active rheumatoid arthritis. Curr. Ther. Res. 1985; 37: 1124–1129
- Koonce M. L., Levy M. E. Long-term study of etodolac in the treatment of patients with osteoarthritis. Todays Ther. Trends. 1984; 2: 1–74. Koonce M. L., Levy M. E. Long-term study of etodolac in the treatment of patients with osteoarthritis. Todays Ther. Trends. 1984; 2: 1–7
- McCarty D. Arthritis and Allied Conditions, 9th Edit. Lea and Febiger, Philadelphia 1979; 1325. McCarty D. Arthritis and Allied Conditions, 9th Edit. Lea and Febiger, Philadelphia 1979; 132
- Sanda M., Collins S. H., Mahady J., Huth J., Krantz K. Three-month multicenter study of etodolac (Ultradol) in patients with osteoarthritis of the hip. Curr. Ther. Res. 1983; 33: 782–7926. Sanda M., Collins S. H., Mahady J., Huth J., Krantz K. Three-month multicenter study of etodolac (Ultradol) in patients with osteoarthritis of the hip. Curr. Ther. Res. 1983; 33: 782–792
- Sanda M., Jacob G., Shand D. B. A safety profile of etodolac in arthritics: clinical experience based on 600 patient-years. Todays Ther. Trends. 1985; 3: 1–157. Sanda M., Jacob G., Shand D. B. A safety profile of etodolac in arthritics: clinical experience based on 600 patient-years. Todays Ther. Trends. 1985; 3: 1–15